안구건조증 치료 기기 시장(2025년) : 세계 시장 분석(2024-2030년)

What's New:

The "2025 Dry Eye Device Market Report" is a newly segmented and expanded analysis, separated for the first time from prior reports that combined both pharmaceutical and device-based therapies into a single report.

By isolating the device market, this new standalone edition allows for deeper insight into procedures, technologies, and treatment pathways specific to dry eye devices. The report delivers more granular analysis of meibomian gland procedures, IPL, punctum plugs, and emerging technologies-along with detailed procedure-based forecasts, regional adoption trends, and competitive dynamics-to provide a clearer, more actionable view of this segment of the dry eye market.

The new first-edition "2025 Dry Eye Device Market Report" delivers a comprehensive analysis of the global market for the devices and procedures used in the diagnosis and treatment of dry eye disease. The report examines the drivers behind device adoption, evaluates current and emerging technologies, and forecasts procedure volumes, unit demand, and market performance through 2030.

Competitive dynamics are analyzed across key product categories, including thermal expression devices, light-based systems, punctum plugs, eyelid debridement, scleral lens and amniotic tissue procedures, and other technologies, with detailed profiles of leading manufacturers and their strategic positioning.

Methodology:

The "2025 Dry Eye Device Market Report" provides a thorough, data-driven assessment of the dry eye device landscape, highlighting critical trends shaping this rapidly evolving segment of ophthalmology. The report tracks global market development and projects growth across major device categories and procedures over the next five years, supported by detailed regional analysis spanning the United States, Western Europe, Japan, China, India, Latin America, and other global markets.

The following is covered in the report:

• Comprehensive overview of dry eye disease, including tear film function, symptoms, risk factors, inflammation, and tear film instability
• Detailed analysis of dry eye prevalence and risk factors across eight global regions, with severity segmentation and diagnosed population estimates
• In-depth review of diagnostic approaches, including traditional clinical methods, tear film-oriented diagnosis, biomarkers, and semi-automated technologies
• Evaluation of dry eye treatment pathways, aligned with DEWS III recommendations and stratified by disease severity
• Analysis of dry eye devices and procedures, including meibomian gland procedures, IPL, low-level light therapy, RF, punctum plugs, and tissue engineering
• Assessment of emerging technologies and device pipeline, highlighting products in development and next-generation treatment approaches
• Global and regional market forecasts, including procedure volumes, treated populations, product category share, and market concentration through 2030
• Regional insights into diagnostic and treatment practices, access barriers, and adoption trends across major ophthalmic markets
• Profiles of leading dry eye device companies, detailing product portfolios, competitive positioning, and strategic outlook